Package 71610-503-80

Brand: terazosin

Generic: terazosin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 71610-503-80
Digits Only 7161050380
Product NDC 71610-503
Description

180 CAPSULE in 1 BOTTLE (71610-503-80)

Marketing

Marketing Status
Marketed Since 2020-12-08
Brand terazosin
Generic terazosin hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b23a32b3-7e6b-4b58-be96-303ac3ef069a", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313217", "313219"], "spl_set_id": ["81d5422c-ff57-4f6d-927c-5de4dd7e1169"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 CAPSULE in 1 BOTTLE (71610-503-60)", "package_ndc": "71610-503-60", "marketing_start_date": "20201208"}, {"sample": false, "description": "180 CAPSULE in 1 BOTTLE (71610-503-80)", "package_ndc": "71610-503-80", "marketing_start_date": "20201208"}], "brand_name": "Terazosin", "product_id": "71610-503_b23a32b3-7e6b-4b58-be96-303ac3ef069a", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "71610-503", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20200330", "listing_expiration_date": "20261231"}